Hyderabad: Amid safety concerns around antiviral drug molnupiravir, the US-based pharma company MSD (Merck is known as MSD outside the US and Canada) came out in defence of its drug developed in collaboration with Ridgeback Biotherapeutics. The company in its statement on Friday, said, “We are confident in the clinical profile of molnupiravir, which demonstrated […]
